Missouri House Bill 2081: Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program
Missouri · 2026 Regular Session
What it does
Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program
Latest action
Referred: Emerging Issues(H) (2026-05-15)
See how HB 2081 affects you on CapitolKey
Browse more bills · CapitolKey home